REPAIR-HD used Huntington’s Disease as a test case for overcoming the challenges of taking stem cell therapies from the laboratory to clinical trial. Doing so develops European capacity to tap emergent therapies for a broad range of human neurodegenerative diseases.
Huntington’s Disease (HD) presents a good clinical model for research into how stem cell therapy could repair the affected brain cells in a range of neurodegenerative disorders.
Further details: Closer to a stem cell therapy for Huntington’s Disease